We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Owlstone Medical Raises $15 million USD to Drive Commercialization of its Breath Biopsy Platform

News   Mar 05, 2018 | Original story from Owstone Medical

 
Owlstone Medical Raises $15 million USD to Drive Commercialization of its Breath Biopsy Platform

Billy Boyle, CEO, Owlstone Medical

 
 
Advertisement
 

RELATED ARTICLES

New Anti-Alzheimer's Compound Reverses Memory Decline in Mice

News

A drug candidate previously shown to slow aging in brain cells has successfully reversed memory loss in a mouse model of inherited Alzheimer’s disease.

READ MORE

"Floppy" Proteins Used To Create Artificial Organelles Within Human Cells

News

Biomedical engineers have developed a method for controlling the phase separation of an emerging class of proteins to create artificial membrane-less organelles within human cells.

READ MORE

Simpler, High-Accuracy Method Detects Rare Circulating Tumor Cells

News

Researchers have demonstrated the effectiveness of a new machine learning technique to analyze the presence of rare circulating tumor cells in blood.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE